Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

RX Pizza: 1 Free Meal Can Sway Doctor Prescribing

By Lindsay Tanner, AP Medical Writer | June 22, 2016

As little as one free meal from a drug company can influence which medicines doctors prescribe for Medicare patients, according to a study using Medicare records and recently released data from the health care law’s Open Payments program.

The study highlights the subtle ways doctors may feel inclined to prescribe a drug after receiving just a small gift, even if the drug is more costly for patients and their insurance plans, the study authors said.

In a typical scenario, drug companies sometimes sponsor meals served during medical conferences and their sales reps may offer drug information and free samples to doctors waiting in line for food.

Dr. Adams Dudley, the study’s lead author, said that happened to him as a young physician – and it led him to prescribe brand-name drugs.

“Having just accepted even just a slice of pizza, you’re going to feel like, ‘Hey, I should let them talk to me,'” he said. “Doctors are human, and humans respond to gifts.”

The researchers calculated that an estimated $73 billion yearly could be saved if equivalent generics were prescribed instead of brand-name drugs, and patients pay for one-third of that excess cost.

“It’s not that it’s medically bad” for patients, Dudley said. “But it is definitely costing them more.”

The bottom line for patients? “Always ask if there’s a generic that’s just as good,” said Dudley, director of the Center for Healthcare Value at the University of California, San Francisco.

The Pharmaceutical Research and Manufacturers of America, an industry group, says it has a voluntary code that sets a $100 limit on “educational items” for doctors and says “modest occasional meals are permitted.”

Holly Campbell, a spokeswoman for the group, said the study “cherry-picks physician prescribing data for a subset of medicines to advance a false narrative” and doesn’t prove free meals influenced prescribing patterns.

The study involved prescribing information for nearly 280,000 doctors in Medicare’s prescription drug program. The researchers examined data on more than 63,000 drug company payments to these doctors from August through December 2013, made available under President Barack Obama’s health care law. Most payments were free meals worth less than about $20.

The researchers included four classes of drugs – statins, antidepressants and two that treat blood pressure. They chose top-selling brand-name drugs from each class for which they said evidence shows there are equally effective but cheaper generic versions: Crestor for cholesterol problems, Benicar and Bystolic for high blood pressure, and Pristiq for depression.

Doctors who received a free meal sponsored by makers of these drugs were more likely to prescribe that drug than doctors who received no free meals. The strongest link was for Pfizer’s Pristiq: doctors who received one Pfizer-sponsored meal were two times more likely to prescribe that drug than doctors who received no freebies.

Doctors’ prescribing rates for these drugs increased as the number of sponsored meals they accepted increased. Patients in Medicare part D (prescription) plans typically pay $4 or less for generics, versus around $40 for brand-name drugs, Dudley said.

American Medical Association voluntary ethics guidelines say doctors should decline any gifts including meals “for which reciprocity is expected or implied.”

Representatives for the companies involved said doctors are not paid to prescribe their products. Sales’ reps interactions with physicians over sponsored meals are an important part of educating them about drugs’ risks and benefits, the companies said in emailed statements.

Dr. Nitin Damle, an internist and president of the American College of Physicians, said modest gifts or meals can be ethical if they enhance patients’ care, but that doctors should ask “‘what would the public or my patients think about this particular gift or meal and what is the purpose of industry offering it to me?'”

The results were published Monday in the journal JAMA Internal Medicine.


Filed Under: Drug Discovery

 

Related Articles Read More >

Bayer’s Lynkuet approved by FDA for menopausal hot flashes
How stereo-correct data can de-risk AI-driven drug discovery
eConsent as the digital foundation for modern clinical trials 
Female Patient Being Reassured By Doctor In Hospital Room
Q&A: Thermo Fisher’s Luke Wilson on hitting 100% dose delivery with patient-centric supply
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE